The forces of globalization and the development of international pharmaceutical policies have significantly affected the way in which drugs are currently distributed. An increased focus on Corporate Social Responsibility (CSR) should help address these disparities and hopefully improve the...

This report discusses data suggesting that ulterior profit motives may be at the heart of the recent increase in pharmaceutical philanthropy carried out through patient assistance programs (PAPs). The author argues that further research is necessary to explore the cost burden PAPs impose on...